21.55

1.32% 0.28

Fulgent Genetics Inc (FLGT)

Overview News Price History Option Chain Financials Discussions Forecast

Fulgent Genetics Inc stock is traded at $21.55, with a volume of 360.61K. It is up +1.32% in the last 24 hours and up +10.80% over the past month. Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.

Previous Close:

$21.27

Open:

$21.28

24h Volume:

360.61K

Relative Volume:

1.22

Market Cap:

$592.95M

Revenue:

$320.35M

Net Income/Loss:

$-75.01M

P/E Ratio:

-8.9968

EPS:

-2.3953

Net Cash Flow:

$-113.17M

1W Performance:

-1.37%

1M Performance:

+10.80%

6M Performance:

+31.88%

1Y Performance:

-2.49%

1-Day Range:

$21.27

$21.87

1-Week Range:

$21.01

$21.93

52-Week Range:

$13.46

$31.04

Fulgent Genetics Inc Stock (FLGT) Company Profile

Name

Fulgent Genetics Inc

Sector

Healthcare (1068)

Industry

Diagnostics & Research (49)

Phone

626-350-0537

Address

4399 SANTA ANITA AVE, EL MONTE

Employee

1,315

Twitter

@FulgentGenetics

Next Earnings Date

2026-11-06

Latest SEC Filings

FLGT's Discussions on Twitter

Compare FLGT vs TMO, DHR, NTRA, A, IQV

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
FLGT Fulgent Genetics Inc	21.55	592.95M	320.35M	-75.01M	-113.17M	-2.3953
TMO Thermo Fisher Scientific Inc	678.39	250.83B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	223.77	157.31B	24.78B	3.68B	5.29B	5.1743
NTRA Natera Inc	408.79	58.92B	2.50B	-226.32M	71.51M	-1.6412
A Agilent Technologies Inc	172.84	48.73B	7.23B	1.41B	1.09B	4.979
IQV Iqvia Holdings Inc	275.02	45.27B	16.63B	1.39B	2.12B	8.0674

Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-05-25	Upgrade	UBS	Neutral → Buy
Dec-07-23	Initiated	UBS	Neutral
Dec-08-22	Downgrade	Piper Sandler	Overweight → Neutral
Nov-18-22	Initiated	Raymond James	Outperform
Aug-25-22	Initiated	Credit Suisse	Outperform
Feb-04-22	Resumed	Piper Sandler	Overweight
Aug-05-21	Resumed	Credit Suisse	Underperform
Jan-08-21	Downgrade	Credit Suisse	Neutral → Underperform
Nov-24-20	Downgrade	BTIG Research	Buy → Neutral
Aug-20-20	Initiated	Oppenheimer	Outperform
May-29-20	Initiated	BTIG Research	Buy
Nov-05-19	Upgrade	Piper Jaffray	Neutral → Overweight
Mar-01-18	Downgrade	Piper Jaffray	Overweight → Neutral
Nov-07-17	Downgrade	Raymond James	Outperform → Mkt Perform

View All

Fulgent Genetics Inc Stock (FLGT) Latest News

Sep 22, 2026

PRPO vs. FLGT: Which Cancer Diagnostics Stock Has More Upside Now? - TradingView

Sep 22, 2026

Sep 21, 2026

Epic Aura integration to add Fulgent Genetics testing to provider workflows - Traders Union

Sep 21, 2026

Think Outside the Box With These 3 Companies That Make Unusual Business Models Work - The Globe and Mail

Sep 21, 2026

Sep 18, 2026